This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

Browsing articles in "Anxiety/Stress-Related Disorders"

Mental Health Impacts of Climate Change: Educational Toolkit
May 12, 2022

Emerging research suggests that climate change will increase the prevalence of posttraumatic stress disorder, depression, anxiety, psychotic disorders, and suicide. An educational toolkit has been developed to empower students to think critically about structural inequalities that affect them and challenge the assumption that they do not have the capacity to overcome the sociopolitical issues that affect them...

Continue reading (Members only)

Early Life Stress and ADHD
April 5, 2022

In a recent study, the relationship between hypothalamic-pituitary-adrenal (HPA) axis disruption and childhood maltreatment on cognitive functioning in adolescents with attention deficit hyperactivity disorder (ADHD) was examined...

Continue reading (Members only)

Neural Circuits Of Anxiolytic And Antidepressant Pherine Molecules
March 16, 2022

Pherines are a novel class of synthetic neuroactive steroids formulated to engage human nasal chemosensory receptors. They are administered intranasally and detected by olfactory afferents wired directly to the limbic amygdala. Due to this mechanism, they have rapid and potent effects on behavior and the autonomic nervous system...

Racial-Ethnic Disparities in Benzodiazepine Prescriptions for Anxiety in US Emergency Departments
March 2, 2022

Benzodiazepines are often used to treat anxiety and panic disorders. In various medical settings, White patients are more likely to receive a benzodiazepine prescription than non-White patients. Racial-ethnic disparities regarding prescription of opioids exist in the emergency room, however it is unknown whether there are racial disparities in benzodiazepine prescriptions in the...

Continue reading (Members only)

Role Of The Oral-Gut-Microbiome-Brain Axis In Trauma-Related Disorders
February 23, 2022

The microbiome-gut-brain axis has been proposed as a moderator or mediator for posttraumatic stress disorder (PTSD). However, clinical data about this direct relationship are lacking. In a recent cohort study, the associations between the gut microbiome and mental health outcomes...

Continue reading (Members only)

Paternal Prevalence of Comorbid Depression and Anxiety During First Two Years Postpartum
January 4, 2022

A recent longitudinally cohort study examined the prevalence of paternal comorbid depression and anxiety during the first and second year postpartum and investigated the predictors for comorbidity during the first and second-year following birth...

Generalized Anxiety Disorder Among Adults With Attention-Deficit Hyperactivity Disorder
December 13, 2021

Attention-deficit hyperactivity disorder and generalized anxiety disorder are highly comorbid; however, there are several potential confounding factors that must be accounted for to determine the degree of their association. Data from a nationally representative cross-sectional survey...

Continue reading (Members only)

Subthreshold PTSD Prevalent and Associated With Substantial Clinical Burden in Older U.S. Veterans
November 22, 2021

Subthreshold posttraumatic stress disorder (PTSD) is characterized by clinically significant PTSD symptoms below the threshold for diagnosis. It is not recognized as a diagnostic entity and is less well studied in older adults, despite its higher prevalence and potential clinical significance. In older adults, PTSD is associated with worse physical, cognitive, and social functioning, as well as...

Continue reading (Members only)

Psilocybin Therapy Increases Cognitive And Neural Flexibility In Patients With Major Depressive Disorder
November 18, 2021

Psilocybin therapy has shown promise in treating major depressive disorder and other psychiatric illnesses. However, the cognitive and neural mechanisms underlying its enduring efficacy is poorly understood. An open-label study examined the enduring effects of psilocybin therapy on the cognitive and neural flexibility...

2021 NEI Congress Child & Adolescent Psychiatry Academy
November 3, 2021

The 2021 NEI Congress is off to a strong start with the 5th Child and Adolescent Psychiatry Academy. Dr. Jeffrey Strawn opened the Academy with a topic of utmost importance as of late, pediatric anxiety. In this session...

Top of Page